Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Final results of a phase III randomized controlled trial comparing modified gemcitabine + oxaliplatin (mGEMOX) to gemcitabine+ cisplatin in management of unresectable gall bladder cancer (GBC).

PaperCitations, authors & open-access status

Final results of a phase III randomized controlled trial comparing modified gemcitabine + oxaliplatin (mGEMOX) to gemcitabine+ cisplatin in management of unresectable gall bladder cancer (GBC). is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 11 citations, 2016 year and closed oa status.

11
Citations
2016
Year
closed
OA Status

Related on ScholarIQ

Seema Mishra
Author
Journal of Clinical Oncology
Journal
Bladder and Urothelial Cancer Treatments
Topic
Bladder and Urothelial Cancer Treatments
Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Topic
Viral-associated cancers and disorders
Topic
470M+ articles · free account